Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 245412, 7 pages
http://dx.doi.org/10.1155/2015/245412
Research Article

After Myocardial Ischemia-Reperfusion, miR-29a, and Let7 Could Affect Apoptosis through Regulating IGF-1

Department of Cardiology, Xi’an Children’s Hospital, No. 69, Xiju Road, Lianhu, Xi’an, Shaanxi 710003, China

Received 29 June 2015; Revised 10 October 2015; Accepted 9 December 2015

Academic Editor: Sung-Hoon Kim

Copyright © 2015 Lei Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. White and L. Launer, “Relevance of cardiovascular risk factors and ischemic cerebrovascular disease to the pathogenesis of Alzheimer disease: a review of accrued findings from the Honolulu-Asia Aging study,” Alzheimer Disease and Associated Disorders, vol. 20, no. 3, supplement 2, pp. S79–S83, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. D. R. Guyer, N. R. Miller, C. L. Auer, and S. L. Fine, “The risk of cerebrovascular and cardiovascular disease in patients with anterior ischemic optic neuropathy,” Archives of Ophthalmology, vol. 103, no. 8, pp. 1136–1142, 1985. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Matías-Guiu, J. Álvarez-Sabín, and A. Codina, “A comparative study of the effect of low doses of acetylsalicylic acid and triflusal in the prevention of cardiovascular incidents in young adults with ischemic cerebrovascular disease,” Revista de Neurologia, vol. 25, no. 147, pp. 1669–1672, 1997. View at Google Scholar · View at Scopus
  4. J. Li, X. Ma, W. Yu et al., “Reperfusion promotes mitochondrial dysfunction following focal cerebral ischemia in rats,” PLoS ONE, vol. 7, no. 9, Article ID e46498, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. Q.-F. Cao, M.-J. Qu, W.-Q. Yang, D.-P. Wang, M.-H. Zhang, and S.-B. Di, “Ischemia postconditioning preventing lung ischemia-reperfusion injury,” Gene, vol. 554, no. 1, pp. 120–124, 2015. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Serose, B. Prudhon, A. Salmon, M.-A. Doyennette, M. Y. Fiszman, and Y. Fromes, “Administration of insulin-like growth factor-1 (IGF-1) improves both structure and function of delta-sarcoglycan deficient cardiac muscle in the hamster,” Basic Research in Cardiology, vol. 100, no. 2, pp. 161–170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. B. P. S. Kang, A. Urbonas, A. Baddoo, S. Baskin, A. Malhotra, and L. G. Meggs, “IGF-1 inhibits the mitochondrial apoptosis program in mesangial cells exposed to high glucose,” American Journal of Physiology—Renal Physiology, vol. 285, no. 5, pp. F1013–F1024, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. T. P. Zwaka, J. Torzewski, A. Hoeflich et al., “The terminal complement complex inhibits apoptosis in vascular smooth muscle cells by activating an autocrine IGF-1 loop,” The FASEB Journal, vol. 17, no. 10, pp. 1346–1348, 2003. View at Google Scholar · View at Scopus
  9. R. N. Wine, C. A. McPherson, and G. J. Harry, “IGF-1 and pAKT signaling promote hippocampal CA1 neuronal survival following injury to dentate granule cells,” Neurotoxicity Research, vol. 16, no. 3, pp. 280–292, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. N. N. Rizk, J. Myatt-Jones, J. Rafols, and J. Dunbar, “Insulin like growth factor-1 (IGF-1) decreases ischemia-reperfusion induced apoptosis and necrosis in diabetic rats,” Endocrine, vol. 31, no. 1, pp. 66–71, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. P. H. Frederikse, R. Donnelly, and L. M. Partyka, “miRNA and Dicer in the mammalian lens: expression of brain-specific miRNAs in the lens,” Histochemistry and Cell Biology, vol. 126, no. 1, pp. 1–8, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Utsunomiya, D. Ishikawa, M. Asanoma et al., “Specific miRNA expression profiles of non-tumor liver tissue predict a risk for recurrence of hepatocellular carcinoma,” Hepatology Research, vol. 44, no. 6, pp. 631–638, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Li, C.-J. Shen, É. A. Cohen, S.-D. Xiong, and J.-H. Wang, “miRNA-1236 inhibits HIV-1 infection of monocytes by repressing translation of cellular factor VprBP,” PLoS ONE, vol. 9, no. 6, Article ID e99535, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. X. Zhong, Y. Liao, L. Chen et al., “The microRNAs in the pathogenesis of metabolic memory,” Endocrinology, vol. 156, no. 9, pp. 3157–3168, 2015. View at Publisher · View at Google Scholar
  15. X. Yu and Z. Li, “The role of microRNAs expression in laryngeal cancer,” Oncotarget, vol. 6, no. 27, pp. 23297–23305, 2015. View at Publisher · View at Google Scholar
  16. R. M. Millis, Z. V. Alvin, A. Zhao, and G. E. Haddad, “Effects of IGF-1 on IK and IK1 channels via PI3K/Akt signaling in neonatal cardiac myocytes,” International Journal of Cell Biology, vol. 2012, Article ID 712153, 6 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. Cao, A. J. Gunn, L. Bennet et al., “Insulin-like growth factor (IGF)-1 suppresses oligodendrocyte caspase-3 activation and increases glial proliferation after ischemia in near-term fetal sheep,” Journal of Cerebral Blood Flow and Metabolism, vol. 23, no. 6, pp. 739–747, 2003. View at Google Scholar · View at Scopus
  18. A. P. Rolo, J. S. Teodoro, C. Peralta, J. Rosello-Catafau, and C. M. Palmeira, “Prevention of I/R injury in fatty livers by ischemic preconditioning is associated with increased mitochondrial tolerance: the key role of ATPsynthase and mitochondrial permeability transition,” Transplant International, vol. 22, no. 11, pp. 1081–1090, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. W. Bi, Y. Bi, P. Xue et al., “Synthesis and characterization of novel indole derivatives reveal improved therapeutic agents for treatment of ischemia/reperfusion (I/R) injury,” Journal of Medicinal Chemistry, vol. 53, no. 18, pp. 6763–6767, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. F. H. Ebner, E. Darra, S. Mariotto, H. Suzuki, and E. Cavalieri, “Use of STAT1 inhibitors in the treatment of brain I/R injury and neurodegenerative diseases,” Central Nervous System Agents in Medicinal Chemistry, vol. 11, no. 1, pp. 2–7, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. J. E. Gschwend, “Apoptosis—principles and importance of programmed cell death for prostatic carcinoma,” Urologe A, vol. 35, no. 5, pp. 390–399, 1996. View at Google Scholar
  22. A. Kahraman, G. Gerken, and A. Canbay, “Apoptosis in immune-mediated liver diseases,” Digestive Diseases, vol. 28, no. 1, pp. 144–149, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. S. L. Sankari, N. Aravindha Babu, E. Rajesh, and M. Kasthuri, “Apoptosis in immune-mediated diseases,” Journal of Pharmacy and Bioallied Sciences, vol. 7, supplement 1, pp. S200–S202, 2015. View at Google Scholar
  24. R. B. B. Jensen, M. Chellakooty, S. Vielwerth et al., “Intrauterine growth retardation and consequences for endocrine and cardiovascular diseases in adult life: does insulin-like growth factor-I play a role?” Hormone Research, vol. 60, supplement 3, pp. 136–148, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. K. W. Kelley, W. A. Meier, C. Minshall et al., “Insulin growth factor-I inhibits apoptosis in hematopoietic progenitor cells. Implications in thymic aging,” Annals of the New York Academy of Sciences, vol. 840, pp. 518–524, 1998. View at Publisher · View at Google Scholar · View at Scopus